The number of subjects undergoing major noncardiac surgery who are at risk for
perioperative myocardial infarction (MI) is growing worldwide.
It has been estimated that 500,000 to 900,000 patients suffer major perioperative cardiovascular complications every year, with consequent heavy, long-term prognostic implications and costs.
It is well known that perioperative MIs don’t share the same pathophysiology as nonsurgical MIs but the relative role of the different, potential triggers has not been completely clarified.
Many aspects of the perioperative management, including risk-stratification and prophylactic or postoperative interventions have also not been completely defined.
Throughout recent years many resources have been invested to clarify these aspects and experts have developed indices and algorithm-based strategies to better assess the cardiac risk and to guide the perioperative management.
The scope of the present review is to discuss the main aspects of perioperative MI in noncardiac surgery, with particular regard to epidemiology, pathophysiology, preoperative risk stratification, prophylaxis and therapy. (Heart International 2006; 2: 82-93)
Myocardial infarction, Noncardiac surgery, Cardiac risk
Dr. Stefano Lucreziotti, U.O. Cardiologia, Azienda Ospedaliera S. Paolo, Via di Rudinì, 8, 20142 Milano, email@example.com
Share this Article
Related Content In Cardiovascular Disease
Foreword: Heart International. 2021;15(1):1
Welcome to the summer 2021 edition of Heart International. This issue contains 9 informative review articles on a range of topics which we hope will be of interest to all cardiovascular practitioners, regardless of subspecialism. We begin with a review by Chu and Gupta, who explore the use of etripamil nasal spray, a novel preparation […]
Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
Heart International. 2021;15(1):14-19 DOI: https://doi.org/10.17925/HI.2021.15.1.14
Peripheral artery disease (PAD) is a severe manifestation of systemic atherosclerotic disease that commonly refers to lower-extremity arterial involvement. The global burden of PAD is estimated to involve over 200 million patients, with prevalence increasing by 24% over the past decade.1 In contrast to myocardial infarction and stroke, which are declining in the USA, the […]
Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk
Heart International. 2021;15(1):26-36 DOI: https://doi.org/10.17925/HI.2021.15.1.26
Coronary artery disease (CAD) is encountered on a daily basis in the field of medicine. Between 2009 and 2012, the global prevalence of CAD was 154 million, based on data from the Global Burden of Disease study; for the same period in the USA, it was approximately 15.5 million, based on data collected by the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!